CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Seok Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Clin Mol Hepatol. 2023;29(3):830-830. Published online 2023 April 13 DOI: https://doi.org/10.3350/cmh.2022.0345e

Erratum to ‘Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in directacting antiviral failure in South Korea’ [Clin Mol Hepatol 2023;29:496-509]

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Seok Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Clinical and Molecular Hepatology. 2023;29(3):830-830

Link1

Link2 Link3

Next-generation sequencing analysis of hepatitis C virus resistance–associated substitutions in direct-acting antiviral failure in South Korea

Kyung-Ah Kim, Sejoon Lee, Hye Jung Park, Eun Sun Jang, Youn Jae Lee, Sung Bum Cho, Young Suk Kim, In Hee Kim, Byung Seok Lee, Woo Jin Chung, Sang Hoon Ahn, Seungtaek Kim, Sook Hyang Jeong

Clinical and Molecular Hepatology. 2023;29(2):496-509

Link1

Link2 Link3

Erratum to ‘History and future of hepatitis B virus control in South Korea’ [Clin Mol Hepatol 2021;27:620-622]

Do Young Kim

Clinical and Molecular Hepatology. 2022;28(4):939-939

Link1

Link2 Link3

Erratum to ‘Is liver biopsy essential to identifying the immune tolerant phase of chronic hepatitis B?’ [Clin Mol Hepatol 2023;29:367-370]

Joo Hyun Oh, Dong Hyun Sinn

Clinical and Molecular Hepatology. 2023;29(3):828-829

Link1

Link2 Link3

History and future of hepatitis B virus control in South Korea

Do Young Kim

Clinical and Molecular Hepatology. 2021;27(4):620-622

Link1

Link2 Link3

Hepatitis C virus infection in patients with hemophilia in Korea: Is antiviral therapy effective and safe?

Woo Sun Rou, Byung Seok Lee

Clinical and Molecular Hepatology. 2015;21(2):122

Link1 Link2 Link3

Another oral antiviral treatment, but still far away from hepatitis B virus cure

Tai-Chung Tseng

Clinical and Molecular Hepatology. 2021;27(2):281-282

Link1

Link2 Link3

Resistance-associated substitutions described after failure of anti-NS5A direct-acting antiviral treatment in 58 hepatitis C virus (HCV) infected patients in Cameroon

Serge Tchamgoue, Maurelle Magatsing, Tatiana Nganso, Marthe Ntep Eboko, Mathurin Kowo, Christian Tzeuton

Journal of Hepatology. 2023;78:S1210-S1211

Link1 Link2

Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

Rita Tavares, Ana Cristina Feldner, João Renato Pinho, Fernanda Malta, Roberto Carvalho-Filho, Rúbia Santana, Vanessa Fusco Duarte de Castro, Gregório Dastoli, Juliana Custódio Lima, Maria Lucia Ferraz

Infection and Drug Resistance. 2018;Volume 12:65-66

Link1 Link2

Options for the management of antiviral resistance during hepatitis B therapy: reflections on battles over a decade

Hyung Joon Yim, Seong Gyu Hwang

Clinical and Molecular Hepatology. 2013;19(3):195

Link1 Link2 Link3

This metadata service is kindly provided by CrossRef from May 29, 2014. Clin Mol Hepatol has participated in CrossRef Text and Data Mining service since March 1, 2015.